相似文献
1
Paediatric HIV infection: the potential for cure.
Nat Rev Immunol. 2016 Apr;16(4):259-71. doi: 10.1038/nri.2016.19. Epub 2016 Mar 14.
2
Anti-retroviral therapy failure in HIV-1 infected pregnant women and its associated risk of HIV transmission.
Arch Gynecol Obstet. 2020 Nov;302(5):1229-1235. doi: 10.1007/s00404-020-05743-8. Epub 2020 Aug 14.
3
4
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
5
Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers.
AIDS. 2005 Jul 1;19(10):1071-9. doi: 10.1097/01.aids.0000174454.63250.22.
6
British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).
HIV Med. 2014 Sep;15 Suppl 4:1-77. doi: 10.1111/hiv.12185.
7
The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.
Clin Infect Dis. 2012 Sep;55(6):877-84. doi: 10.1093/cid/cis535. Epub 2012 Jun 6.
8
Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.
AIDS. 2015 Nov 28;29(18):2534-7. doi: 10.1097/QAD.0000000000000888.
9
Prevention of perinatal HIV transmission during pregnancy.
J Antimicrob Chemother. 2000 Nov;46(5):657-68. doi: 10.1093/jac/46.5.657.
10
Unexpected vertical transmission of HIV infection.
Eur J Pediatr. 2014 Jan;173(1):121-3. doi: 10.1007/s00431-013-2020-9. Epub 2013 May 8.
引用本文的文献
1
Impact of Delayed Early Antiretroviral Therapy Initiation on Treatment Outcomes in Infant Macaques Exposed to SHIVAD8.
Viruses. 2025 Jun 14;17(6):849. doi: 10.3390/v17060849.
2
The Complex Role of CD8+ T Cells in Placental HIV Infection.
Eur J Immunol. 2025 Jun;55(6):e51615. doi: 10.1002/eji.202451615.
3
Intact HIV DNA decays in children with and without complete viral load suppression.
PLoS Pathog. 2025 Apr 4;21(4):e1013003. doi: 10.1371/journal.ppat.1013003. eCollection 2025 Apr.
4
Autovaccination revisited: potential to boost antiviral immunity and facilitate HIV-1 cure/remission in children.
Curr Opin HIV AIDS. 2025 May 1;20(3):271-278. doi: 10.1097/COH.0000000000000924. Epub 2025 Mar 19.
5
Divergent populations of HIV-infected naive and memory CD4+ T cell clones in children on antiretroviral therapy.
J Clin Invest. 2025 Mar 6;135(9). doi: 10.1172/JCI188533. eCollection 2025 May 1.
6
Human models that inform antiretroviral therapy-free remission with perinatally acquired HIV infection.
Curr Opin HIV AIDS. 2025 May 1;20(3):249-256. doi: 10.1097/COH.0000000000000918. Epub 2025 Mar 19.
7
Long-term non-progression in children with HIV: estimates from international cohort data.
AIDS. 2025 May 1;39(6):746-759. doi: 10.1097/QAD.0000000000004136. Epub 2025 Feb 4.
8
Interventions during Early Infection: Opening a Window for an HIV Cure?
Viruses. 2024 Oct 9;16(10):1588. doi: 10.3390/v16101588.
9
Assessing the impact of autologous virus neutralizing antibodies on viral rebound time in postnatally SHIV-infected ART-treated infant rhesus macaques.
Epidemics. 2024 Sep;48:100780. doi: 10.1016/j.epidem.2024.100780. Epub 2024 Jun 27.
10
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.
Nat Med. 2024 Oct;30(10):2796-2804. doi: 10.1038/s41591-024-03105-4. Epub 2024 Jun 6.
本文引用的文献
1
HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
Lancet HIV. 2016 Jan;3(1):e49-54. doi: 10.1016/S2352-3018(15)00232-5. Epub 2015 Dec 9.
2
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.
Lancet HIV. 2015 Dec;2(12):e520-9. doi: 10.1016/S2352-3018(15)00226-X. Epub 2015 Nov 17.
3
Blood-Derived CD4 T Cells Naturally Resist Pyroptosis during Abortive HIV-1 Infection.
Cell Host Microbe. 2015 Oct 14;18(4):463-70. doi: 10.1016/j.chom.2015.09.010.
4
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption.
Nat Commun. 2015 Oct 9;6:8495. doi: 10.1038/ncomms9495.
5
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.
Lancet HIV. 2014 Oct;1(1):e13-21. doi: 10.1016/S2352-3018(14)70014-1. Epub 2014 Sep 15.
6
Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection.
PLoS Pathog. 2015 Sep 24;11(9):e1005153. doi: 10.1371/journal.ppat.1005153. eCollection 2015 Sep.
7
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
PLoS Pathog. 2015 Sep 17;11(9):e1005142. doi: 10.1371/journal.ppat.1005142. eCollection 2015 Sep.
8
Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point.
Immunity. 2015 Sep 15;43(3):591-604. doi: 10.1016/j.immuni.2015.08.012. Epub 2015 Sep 8.
9
CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies.
Mol Psychiatry. 2016 Apr;21(4):574-84. doi: 10.1038/mp.2015.111. Epub 2015 Aug 25.
10
Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
Clin Infect Dis. 2015 Dec 15;61(12):1862-70. doi: 10.1093/cid/civ688. Epub 2015 Aug 13.
Zotero 插件